• Sequencing therapies in R/R NHL: immunotherapy in DLBCL, BTKis in MCL, & more!

  • Apr 14 2025
  • Duración: 46 m
  • Podcast

Sequencing therapies in R/R NHL: immunotherapy in DLBCL, BTKis in MCL, & more!

  • Resumen

  • This podcast episode features experts Paolo Strati, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, Gloria Iacoboni, MD, PhD, Vall d’Hebron Institute of Oncology, Barcelona, Spain, and Manali Kamdar, MD, University of Colorado Cancer Center, Denver, CO, who discuss the sequencing of therapies in relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL). They focus on the sequencing of CAR T-cells and bispecific antibodies in diffuse large B-cell lymphoma (DLBCL), the use of BTK inhibitors (BTKis) in mantle cell lymphoma (MCL), and advances in the treatment of follicular lymphoma.

    Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Sequencing therapies in R/R NHL: immunotherapy in DLBCL, BTKis in MCL, & more!

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.